Form 4: Guardant Health Director Sells Shares Under Pre-Arranged Plan

Guardant Health Director Tariq Musa sold 116 shares of common stock for $48.20 per share on July 17, 2025, as part of a Rule 10b5-1 trading plan.

Summary

• Tariq Musa, a Director of Guardant Health, Inc. (GH), reported a transaction involving the company's common stock.
• On July 17, 2025, Tariq Musa disposed of 116 shares of Guardant Health common stock.
• The shares were sold at a price of $48.20 per share.
• Following this transaction, Tariq Musa beneficially owns 7,324 shares of Guardant Health common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sale of shares by a director, while a reduction in insider ownership, was conducted under a pre-arranged Rule 10b5-1 plan, which typically indicates a scheduled transaction rather than a reaction to new information, thus maintaining a neutral sentiment.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating it was a pre-scheduled sale and not necessarily a reaction to recent company performance or news.

Negatives

• A director's sale of shares, even if pre-planned, results in a reduction of insider ownership in the company.

Risks

• No specific new risks are disclosed in this Form 4 filing beyond the inherent risk associated with any insider selling, which is mitigated by the Rule 10b5-1 plan.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is solely a report of an insider transaction.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Minimal direct impact on shareholders due to the small number of shares sold (116 shares) relative to the company's total outstanding shares and the director's remaining holdings (7,324 shares).

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Transaction, Stock Sale, Director, Tariq Musa, Rule 10b5-1